Saturday 17 October 2026 Export CORT’s income statement to Excel — free account

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024. In the quarter to June 2026, revenue grew 31.7%, EPS grew 21.2% and free cash flow fell 29.9%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.

110.16 3.21 −2.83%

Follow CORT

Alert me

Market cap: $12.3B
P/E: 212×
Fwd P/E: 139×
Dividend yield: —
F-score: 4/9
Altman Z: 14.11
Beneish M: −2.76
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	8.08%	7.07%	14.79%	16.47%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	5	5	4	5
ROA Full definition →	6.41%	5.62%	11.71%	13.02%
ROIC Full definition →	1.01%	(1.71%)	9.98%	19.01%
Return on Tangible Assets Full definition →	18.63%	16.67%	30.56%	28.22%
Average Days of Receivables Full definition →	33.79	18.54	28.66	34.29
Free Cash Flow per Share Full definition →	1.01	1.15	1.37	1.58
Free Cash Flow Full definition →	106.92	120.15	141.79	163.32
Capital Expenditures Full definition →	(2.78)	(0.31)	(0.21)	(0.28)
Other line items
Cash ROIC Full definition →	10.54%	12.31%	13.83%	15.42%
Accounts Receivable Turnover Full definition →	11.74	15.25	13.39	11.46
Accounts Payable Turnover Full definition →	0.73	0.44	0.47	0.50
Inventory Turnover Full definition →	1.11	0.99	1.03	1.31
Average Days of Payables Full definition →	386.38	903.37	1,137.56	939.11
Days of Inventory on Hand Full definition →	341.68	349.62	361.93	336.67
Tax Rate Full definition →	1.09	2.90	0.50	0.20
Research and Development Expense of Revenue Full definition →	30.56%	33.86%	33.48%	35.13%
Selling, General and Administrative Expense of Revenue Full definition →	66.98%	65.46%	58.93%	54.22%
Share Based Compensation of Revenue Full definition →	11.57%	11.14%	11.10%	10.86%
Operating CF/Net income Full definition →	2.02	2.58	1.45	1.56
Depreciation/Fixed assets Full definition →	(0.52)	(0.97)	(1.70)	(4.33)
Capex/Depreciation Full definition →	1.04	0.10	0.07	0.03
Revenue per Share Full definition →	7.88	7.36	7.33	7.16
Operating CF per Share Full definition →	1.04	1.15	1.37	1.58
Capex per Share Full definition →	(0.03)	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly